Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7373 p538
29 October 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


New Numark chairman

David Cole, chief executive of Phoenix, has become chairman of Numark, following the company's purchase by Phoenix (PJ, 15 October, p471). David Wood, previously chief executive officer of Numark, has left the business. Simon Colebeck, has been appointed managing director of Numark.

Back to Top


©The Pharmaceutical Journal